Cognitive mechanisms for inferring the meaning of novel signals during symbolisation - Fig 5 by Justin Sulik (4768296)

Oxidative stress (OS) responses in the testis tissues. by Cao Wang (1500691)

Decreased IFNγ production by BcA9 NK cells is independent of impaired MAP kinase pathway signaling or RNA instability. by Nassima Fodil (669326)

Flagella numbers and flagellar class II and class III gene expression are decreased in a Δ<i>rfaG</i> mutant. by Julia Andrea Deditius (782678)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em>_g levels by Dieter Gerten (557088)

“…Other regions would be affected at higher Δ<em>T</em>_g levels, with lower intensity or with lower confidence. In total, mean global warming levels of 2 ° C, 3.5 ° C and 5 ° C are simulated to expose an additional 8%, 11% and 13% of the world population to new or aggravated water scarcity, respectively, with >50% confidence (while ~1.3 billion people already live in water-scarce regions). …”

Plot of mean simulated power with 95 percentile (2.5 & 97.5%) for select DNAm differences. by Jacquelyn Y. Taylor (6386456)

A Yoga Strengthening Program Designed to Minimize the Knee Adduction Moment for Women with Knee Osteoarthritis: A Proof-Of-Principle Cohort Study by Elora C. Brenneman (795723)

“…A secondary objective was to determine whether the program could improve mobility and fitness, and decrease peak KAM during gait. …”

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

“…The pre-defined secondary outcomes were better in the Tac group compared to the control group. The frequency of decrease in pcUACR and percentage change of UPCR (pcUPCR) ≥50% at 16 weeks were 65.0% (13/20) and 55.0% (11/20)in the Tac group, and 25.0% (5/20) and 15.0% (3/20), in the control group, respectively (p = 0.025 for pcUACR and p = 0.019 for pcUPCR). …”

Nonmetric multidimensional scaling ordination of bryophytes on a matrix of 94 plots by 5 species groups along the DMTS haul road in Cape Krusenstern National Monument, Alaska. by Peter N. Neitlich (4034300)

Reduced follicles, decreased ovulation and decreased fertilization of female Meox-2-cre/Separase S1121A mutant mice. by Juan Xu (225010)

Decrease in comet tail moment (TM) with increasing concentration of () melphalan and () SJG-136 in AA8 cells by Peter H. Clingen (9612)

Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

“…Compared to the original model, P-YOLOv5s-GRNF decreased parameters by 18%, decreased model size to 11.9MB, decreased FLOPs to 14.5G, and increased FPS by 4.3. …”

LiCl and MTR decrease polyQ toxicity measuring ASH neuronal death in the absence of growth. by Cindy Voisine (30589)

<i>N</i>-acylethanolamine hydrolysis inhibitors decrease N1E-115 cell viability. by Laurie Hamtiaux (199349)

Effect of perfusion with VEGF121 on outflow facility. by Tomokazu Fujimoto (709192)

Subcutaneous injections of IL-2 decrease PD-1 expression in CD4+ and CD8+ T cells. by Vedran Brezar (337452)

Structurally distinct inhibitors of Chk1 decrease Chk1 nuclear fluorescence following heating in a low well volume. by Andrew J. Massey (239469)

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulat... by Rodrigo A Fuentealba (77901)

“…<p><b>Copyright information:</b></p><p>Taken from "ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of γ-secretase activity"</p><p>http://www.molecularneurodegeneration.com/content/2/1/14</p><p>Molecular Neurodegeneration 2007;2():14-14.…”